biotech.today

Details

  • ●Modalities: small molecules
  • ●Therapeutic areas: oncology, cardiovascular
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: $100M

Partners & investors

  • Pfizer· Investor

Key considerations

  • ●AI tools in use: XtalPi ID4 Platform
  • ●HKEX IPO 2024
  • ●Pfizer $100M+ multi-target deal
  • ●Multiple China pharma + international partnerships
Get live updates on XtalPi’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Shuhao Wen

Co-Founder & CEO

crystal-structure-predictionai-pharma
Visit website →LinkedIn →